Proteasome Activity Assay Kit ab107921 takes advantage of the chymotrypsin-like activity, using an AMC-tagged peptide substrate (Proteasome Substrate (Succ-LLVY-AMC in DMSO), which releases free, highly fluorescent AMC (Ex/Em 350/440 nm) in the presence of proteolytic activity.
Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
Fluorescent
Cell Lysate
Enzyme activity
Mammals
1h
Proteasome Activity Assay Kit ab107921 takes advantage of the chymotrypsin-like activity, using an AMC-tagged peptide substrate (Proteasome Substrate (Succ-LLVY-AMC in DMSO), which releases free, highly fluorescent AMC (Ex/Em 350/440 nm) in the presence of proteolytic activity.
Individual kit components also available for purchase with a minimum order of 20 units. Contact us to discuss your needs.
Fluorescent
Cell Lysate
Enzyme activity
Mammals
1h
Microplate reader
Blue Ice
-20°C
-20°C
-20°C
Proteasome Activity Assay Kit (ab107921) takes advantage of the chymotrypsin-like activity, using an AMC-tagged peptide substrate (Proteasome Substrate (Succ-LLVY-AMC in DMSO), which releases free, highly fluorescent AMC (Ex/Em 350/440 nm) in the presence of proteolytic activity.
The kit also includes a positive control (Jurkat Cell lysate with significant proteasome activity) and a specific proteasome inhibitor MG-132 which suppresses all proteolytic activity due to proteasomes. This permits differentiation of proteasome activity from other protease activity which may be present in samples.
Proteasome activity assay protocol summary:
- add samples, standards and positive control to wells
- add proteasome inhibitor to half of sample and positive control wells
- add proteasome substrate to sample and control wells
- incubate for 20 min
- analyze with microplate reader, incubate for further 30 min, analyze again
This product is manufactured by BioVision, an Abcam company and was previously called K245 Proteasome Activity Fluorometric Assay Kit. K245-100 is the same size as the 100 test size of ab107921.
The 20S proteasome assembly is the functional protease structure with chymotrypsin-like, trypsin-like and caspase-like protease activities
This supplementary information is collated from multiple sources and compiled automatically.
Proteasomes are large protein complexes responsible for degrading ubiquitinated proteins into peptides. This process is essential for maintaining protein homeostasis within the cell. The proteasome often referred to as the 26S proteasome consists of a core particle with a mass of roughly 700 kDa and a regulatory particle. They are expressed in the cytoplasm and nucleus of eukaryotic cells where they perform the bulk of cellular protein degradation. Other names for the proteasome include multicatalytic proteinase complex and prosome.
The ubiquitin-proteasome system orchestrates the controlled degradation of unneeded or damaged proteins regulating numerous cellular mechanisms. The proteasome forms a complex with ubiquitin chains tagged to substrate proteins guiding them for degradation. Proteasomal activity ensures turnover of proteins involved in cell cycle progression signal transduction and immune responses. By controlling protein levels proteasome function influences many biological outcomes and maintains cellular equilibrium.
The proteasome's function integrates deeply into the ubiquitin-proteasome pathway critical for protein catabolism and cellular control processes. Another significant pathway is the regulation of apoptosis where the proteasome controls the levels of proteins like p53 an important regulator of cell death. In these pathways the proteasome collaborates with other proteins such as ubiquitin ligases playing role in fine-tuning the cellular processes involved in survival and programmed cell death.
Proteasome dysfunction contributes to neurodegenerative diseases like Parkinson's and Alzheimer's. Disruption in proteasomal activity leads to aggregation of damaged proteins which can have pathological consequences. Cancer is another area where proteasomes play an important role; certain cancers show dysregulated proteasomal activity resulting in abnormal degradation of tumor suppressor proteins like p53. Understanding proteasome markers helps in diagnosing and evaluating these diseases linking proteasomes to both prognosis and potential therapeutic interventions.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Standard curve: mean of duplicates (+/- SD) with background reads subtracted
Proteasome Activity measured in Jurkat lysate
Proteasome Activity measured in HeLa lysate
Proteasome Activity measured in cell lysates showing activity (mU) per 1 mln cells.
Samples with the concentration of 3.3e6 cells/mL were used. 50 μl of each sample was used.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com